Saris et al., 2021 - Google Patents
Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19Saris et al., 2021
View PDF- Document ID
- 14642121995642945166
- Author
- Saris A
- Reijnders T
- Nossent E
- Schuurman A
- Verhoeff J
- Van Asten S
- Bontkes H
- Blok S
- Duitman J
- Bogaard H
- Heunks L
- Lutter R
- van der Poll T
- Vallejo J
- Publication year
- Publication venue
- Thorax
External Links
Snippet
Background Knowledge of the pathophysiology of COVID-19 is almost exclusively derived from studies that examined the immune response in blood. We here aimed to analyse the pulmonary immune response during severe COVID-19 and to compare this with blood …
- 210000004369 Blood 0 title abstract description 30
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saris et al. | Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19 | |
| Sefik et al. | A humanized mouse model of chronic COVID-19 | |
| Qin et al. | Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China | |
| Rodriguez et al. | Systems-level immunomonitoring from acute to recovery phase of severe COVID-19 | |
| Vannucchi et al. | Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study | |
| Wildner et al. | B cell analysis in SARS-CoV-2 versus malaria: increased frequencies of plasmablasts and atypical memory B cells in COVID-19 | |
| Giamarellos-Bourboulis et al. | Complex immune dysregulation in COVID-19 patients with severe respiratory failure | |
| Winheim et al. | Impaired function and delayed regeneration of dendritic cells in COVID-19 | |
| Falck-Jones et al. | Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity | |
| Scapini et al. | Human neutrophils in the saga of cellular heterogeneity: insights and open questions | |
| Forcade et al. | Circulating T follicular helper cells with increased function during chronic graft-versus-host disease | |
| Merza et al. | Analysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq | |
| de Kleijn et al. | IFN-γ-stimulated neutrophils suppress lymphocyte proliferation through expression of PD-L1 | |
| Trombetta et al. | Severe COVID-19 recovery is associated with timely acquisition of a myeloid cell immune-regulatory phenotype | |
| Utrero-Rico et al. | Alterations in circulating monocytes predict COVID-19 severity and include chromatin modifications still detectable six months after recovery | |
| Niebuhr et al. | Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans | |
| Tang et al. | Sustained IFN-I stimulation impairs MAIT cell responses to bacteria by inducing IL-10 during chronic HIV-1 infection | |
| Lee et al. | Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection | |
| Suzuki et al. | Reduced immunocompetent B cells and increased secondary infection in elderly patients with severe sepsis | |
| Petrara et al. | Asymptomatic and mild SARS-CoV-2 infections elicit lower immune activation and higher specific neutralizing antibodies in children than in adults | |
| Kudryavtsev et al. | Dysregulated immune responses in SARS-CoV-2-infected patients: a comprehensive overview | |
| Zeng et al. | Dynamic SARS-CoV-2-specific immunity in critically ill patients with hypertension | |
| Halstead et al. | Reduced frequency of CD56dim CD16pos natural killer cells in pediatric systemic inflammatory response syndrome/sepsis patients | |
| Tang et al. | A novel immunomodulatory function of neutrophils on rhinovirus-activated monocytes in vitro | |
| Leonardi et al. | Akt-Fas to quell aberrant T cell differentiation and apoptosis in Covid-19 |